Chemical inhibitors of CSAD can effectively disrupt its normal function through various biochemical interactions. Vigabatrin, for instance, serves as an irreversible inhibitor of GABA transaminase, thereby elevating GABA levels and inducing feedback inhibition of CSAD. Similarly, Valproic Acid raises GABA concentrations by concurrently inhibiting GABA transaminase and succinic semialdehyde dehydrogenase, culminating in a suppressive effect on CSAD through feedback inhibition. L-Cycloserine, through its partial agonism at the glycine modulatory site of the NMDA receptors and inhibition of alanine racemase, alters neurotransmitter equilibrium, which can lead to decreased CSAD activity due to shifts in substrate demand.
Gabaculine's role as an irreversible inhibitor of GABA transaminase further substantiates the pattern of increased GABA levels causing dampened CSAD activity. Aminooxyacetic Acid, while inhibiting multiple aminotransferases, also contributes to this effect by inhibiting GABA transaminase, subsequently influencing CSAD through feedback inhibition. Allylglycine, another GABA transaminase substrate analogue, impedes GABA degradation, indirectly suppressing CSAD activity. Isatin, despite its primary function as an inhibitor of aldehyde oxidase and indoleamine 2,3-dioxygenase, can affect GABA metabolism in a manner that leads to CSAD inhibition. Ethanol escalates GABAergic neurotransmission acutely, which can trigger a compensatory downregulation of GABA synthesis enzymes including CSAD. Phenelzine, though a general MAO inhibitor, can raise GABA levels, leading to indirect feedback inhibition of CSAD. Methionine Sulfoximine, by inhibiting glutamine synthetase, may boost glutamate levels that favor GABA synthesis, ultimately feeding back to inhibit CSAD. Topiramate, by binding to the GABA-A receptor and enhancing GABAergic activity, can cause a reduction in CSAD activity. Lastly, Tiagabine can elevate extracellular GABA by blocking its reuptake, which serves to inhibit CSAD through a feedback mechanism.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Vigabatrin | 60643-86-9 | sc-204382 sc-204382A sc-204382B sc-204382C | 10 mg 50 mg 100 mg 1 g | $125.00 $485.00 $650.00 $1015.00 | 2 | |
Vigabatrin is an irreversible inhibitor of GABA transaminase, the enzyme responsible for the catabolism of GABA. By inhibiting this enzyme, it increases the levels of GABA, which can lead to the inhibition of downstream enzymes that utilize GABA, such as CSAD, due to feedback inhibition mechanisms. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid is known to increase GABA levels in the brain by inhibiting GABA transaminase and succinic semialdehyde dehydrogenase, potentially leading to an accumulation of GABA that could exert inhibitory feedback on enzymes like CSAD involved in GABA synthesis. | ||||||
Gabaculine | 59556-17-1 | sc-200473 sc-200473A sc-200473B | 10 mg 50 mg 250 mg | $354.00 $884.00 $3069.00 | 5 | |
Gabaculine is an irreversible inhibitor of GABA aminotransferase, leading to increased GABA levels, which can subsequently inhibit CSAD activity through feedback inhibition as CSAD is involved in GABA synthesis. | ||||||
Phenethyl-hydrazine | 51-71-8 | sc-331686 | 500 mg | $396.00 | ||
Phenelzine is a non-selective and irreversible inhibitor of monoamine oxidase (MAO). It can increase levels of GABA by inhibiting MAO, which may indirectly inhibit CSAD by increasing GABA levels and subsequent feedback inhibition. | ||||||
L-Methionine [R,S]-Sulfoximine | 15985-39-4 | sc-207806 | 1 g | $396.00 | ||
Methionine Sulfoximine is an inhibitor of glutamine synthetase, potentially increasing glutamate levels which can be converted to GABA, leading to higher GABA concentrations that might inhibit CSAD through feedback inhibition. | ||||||
Topiramate | 97240-79-4 | sc-204350 sc-204350A | 10 mg 50 mg | $107.00 $369.00 | ||
Topiramate enhances GABAergic activity by binding to the GABA-A receptor. The increased GABAergic activity could lead to a reduction in CSAD activity due to feedback inhibition mechanisms. | ||||||